Nataliya V. Lyutenko

Nataliya V. Lyutenko

Auto-generated profile, based on publicly available information

Nataliya V. Lyutenko

V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the NAS of Ukraine, Kyiv, Ukraine

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2024 in Ukrainica Bioorganica Acta
Verified
Journal Article
Open access
PDF file
AWAlicja Wzorek
Alicja Wzorek
JHJianlin Han
Jianlin Han
NLNataliya V. Lyutenko
Nataliya V. Lyutenko
MKManankar Koley
Manankar Koley
ASAlexander E. Sorochinsky
Alexander E. Sorochinsky
VSVadim A. Soloshonok
Vadim A. Soloshonok
In this perspective review article, we discuss application of penicillin acylase for biocatalytic resolution of tailor-made amino acids, in particular α-aminophosphonic acids and fluorine-containing β-amino acids. The method includes preparation of the corresponding N-phenylacetyl derivatives followed by the enzyme-catalyzed hydrolysis of one of the enantiomers. The free amino acid and the remaining N-phenylacetyl derivative are separated simply by cation-exchange chromatography or extraction. The final step is a chemical hydrolysis of the enzymatically unreactive N-phenylacetyl derivative. This approach features exceptionally high enantiomeric purity (>99% ee) of the target amino acids, wide structural generality and operational simplicity boding well for large-scale applications of this biocatalytic approach for preparation of highly biologically relevant unnatural, tailor-made amino acids in enantiomerically pure form

30 June 2023 in Ukrainica Bioorganica Acta
Verified
Journal Article
Open access
PDF file
NLNataliya V. Lyutenko
Nataliya V. Lyutenko
ASAlexander E. Sorochinsky
Alexander E. Sorochinsky
VSVadim A. Soloshonok
Vadim A. Soloshonok
This review article covers the developments made in collaboration by groups of Professors V. P. Kukhar and P. Bravo to the synthetic applications of sulfinyl compounds as versatile chiral auxiliaries for asymmetric preparation of fluorinated amines and amino acids. The potential of the sulfinyl chiral auxiliaries in the field of stereoselective transformations of fluorinated substrates is demonstrated by diastereoselective methylene transfer from diazomethane to the carbonyl of β-keto-γ-fluoroalkyl sulfoxides as a general approach for preparation of various fluorinated oxirane derivatives, diastereoselective sulfoxide anions addition to fluorinated imines leading to convenient preparation of α-fluoroalkyl α-amino acids, hydroxy amines, and amines, diastereoselective Mannich-type reaction between N-tert-butanesulfinyl-3,3,3-trifluoroacetaldimine and protected alkyl glycolates furnishing β-trifluoromethyl isoserine derivatives and diastereoselective additions of phosphite or α-phosphonate anions to N-tert-butanesulfinyl-3,3,3-trifluoroacetaldimine using for synthesis of trifluoromethylated α- and β-aminophosphonic acids. Furthermore, diastereoselective additions of Reformatsky reagent derived from bromodifluoroethyl acetate as well as α,α-difluorophosphonate anions to N-p-toluenesulfinyl imines allowing convenient preparation of a,a-difluoro-b-amino acids and α,α-difluoro-β-amino phosphonates in enantiomerically pure form are described. Effect of fluorine on the mechanism and stereochemical outcome of these reactions is briefly discussed

30 December 2023 in Ukrainica Bioorganica Acta
Verified
Journal Article
Open access
PDF file
AWAlicja Wzorek
Alicja Wzorek
JHJianlin Han
Jianlin Han
NLNataliya V. Lyutenko
Nataliya V. Lyutenko
MKManankar Koley
Manankar Koley
ASAlexander E. Sorochinsky
Alexander E. Sorochinsky
VSVadim A. Soloshonok
Vadim A. Soloshonok
In this perspective review article, we describe the discovery of azomethine-azomethine isomerization of fluorinated N-benzyl-imines and its further development into one of the most convenient, scalable, and practical synthetic methods for preparation of biologically relevant fluorinated amines and amino acids. Currently referred to as 1,3-Proton Shift Reaction, this method is widely used by organic chemists for synthesis of variety fluorinated amino compounds playing important role in the design of modern pharmaceuticals and agrochemicals

15 December 2021 in Chemistry – A European Journal
Verified
Journal Article
Open access
PDF file
JHJianlin Han
Jianlin Han
NLNataliya V. Lyutenko
Nataliya V. Lyutenko
ASAlexander E. Sorochinsky
Alexander E. Sorochinsky
AOAyaka Okawara
Ayaka Okawara
HKHiroyuki Konno
Hiroyuki Konno
VSVadim A. Soloshonok
Vadim A. Soloshonok
In this review article, a detailed and comprehensive overview of the synthetic methods, discussion of the general facets of their biological properties, and most promising applications for five aza-tryptophan derivatives, including aza-substitution in positions 2, 4, 5, 6, and 7 were profiled. For more information, see the Review by Vadim A. Soloshonok et al. on page 17510 ff.

25 May 2026 in Ukrainian Chemistry Journal
Verified
Journal Article
Closed access
AWAlicja Wzorek
Alicja Wzorek
TOTaizo Ono
Taizo Ono
KKKarel D. Klika
Karel D. Klika
NLNatalia Lyutenko
Natalia Lyutenko
VSVadim A. Soloshonok
Vadim A. Soloshonok
In 2025, seven fluorine-containing anticancer agents received approval from the US Food and Drug Administration, underscoring the continued and growing impact of strategic fluorination in modern oncology drug design. These newly authorized therapies represent a diverse portfolio spanning a broad spectrum of malignancies, molecular targets, and innovative mechanisms of action, further validating fluorine’s unique ability to enhance drug performance. Sunvozertinib (Zegfrovy®) was approved for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring specific EGFR mutations. The combination of defactinib and avutometinib (Avmapki®) provides a much-needed targeted option for patients with KRAS-mutated recurrent low-grade serous ovarian cancer, addressing a historically challenging disease setting. Imlunestrant (Inluriyo®) offers a next-ge­neration selective estrogen receptor degrader (SERD) as an effective endocrine therapy for estrogen receptor-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. Ziftomenib (Komzifti®) enables precision therapy for adults with relapsed or refractory (AML) carrying susceptible NPM1 mutations, representing a signi­ficant advancement in targeted hematologic oncology.Datopotamab deruxtecan (Datroway®), a novel TROP2-directed antibody–drug conjugate (ADC) with a topoisomerase I inhibitor payload, expands treatment options for previously treated hormone receptor-positive, HER2-negative metastatic breast cancer and for certain TKI-experienced NSCLC populations. Taletrectinib (Ibtrozi®), a potent next-generation ROS1 tyrosine kinase inhibitor, received approval for ROS1-­positive NSCLC in both TKI-naïve and TKI-experienced patients, offering improved central ner­vous system penetration and activity against resistant mutations.Collectively, these seven agents vividly illustrate the remarkable versatility of fluorine incorporation in enhancing molecular potency, metabolic stability, binding selectivity, and overall pharmacokinetic performance across vastly different therapeutic modalities — from small-molecule kinase inhibitors and degraders to complex antibody–drug conjugates. The strategic placement of fluorine atoms or fluorinated groups in these molecules often leads to improved lipophilicity, stronger target engagement, reduced clearance, and better safety profiles.For each compound, we provide a comprehensive integrated discussion covering its discovery history, detailed biological me­chanism of action, primary therapeutic applications, recommended clinical administration and dosing regimens, the specific role of fluorination in optimizing its pharmacological and physicochemical properties, as well as the detailed chemical synthesis routes employed in its industrial-scale production.

30 December 2023 in Ukrainica Bioorganica Acta
Verified
Journal Article
Closed access
AWAlicja Wzorek
Alicja Wzorek
JHJianlin Han
Jianlin Han
NLNataliya V. Lyutenko
Nataliya V. Lyutenko
MKManankar Koley
Manankar Koley
ASAlexander E. Sorochinsky
Alexander E. Sorochinsky
VSVadim A. Soloshonok
Vadim A. Soloshonok
In this perspective review article, we describe the discovery of azomethine-azomethine isomerization of fluorinated N-benzyl-imines and its further development into one of the most convenient, scalable, and practical synthetic methods for preparation of biologically relevant fluorinated amines and amino acids. Currently referred to as 1,3-Proton Shift Reaction, this method is widely used by organic chemists for synthesis of variety fluorinated amino compounds playing important role in the design of modern pharmaceuticals and agrochemicals